Indian Pharmacovigilance Day 2018 conference was held at Mumbai recently
Several sessions on medical writing, literature searching, evolution of India's pharmacovigilance initiatives were held at the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Sun Pharma announces US FDA approval of Cequa to treat dry eye disease
Cequa (cyclosporine ophthalmic solution) 0.09 per cent for topical ophthalmic use is the only dry eye treatment to combine…
Suven Life Sciences announces financial results for quarter ending June 30, 2018
Suven’s income at INR 1998 mn; PAT at INR 388 Mn for the quarter ended June 2018
AvaMed responds to NPPA’s extension of price-capping on knee implants
AvaMed hoped for a better outcome that values quality, safety and clinical results
IIT Roorkee professor awarded GD Naidu award for work in biomedical nanotechnology
Dr P Gopinath has developed an economical and green way to detect and kill cancer cells and a portable nanofibrous material for…
Kilitch Drugs (India) registers a robust growth in Q1FY19
Net sales up four-folds (YoY) to INR 27.97 crore and registers a net profit of INR 4.17 crore
Sun Pharma reports Q1FY19 results
The gross sales are at INR 7,139 crores up 16 per cent and adjusted net profit is at INR 983 crores up 87 per cent
DOP organises Indian Pharma Expo 2018
Indian Pharma Expo (IPE) 2018 held on August 7, 8 and 9, 2018 at Pragati Maidan, New Delhi
Epygen Biotech, first company in India to acquire licensing of Novel Biological Entity (NBE)
The company has acquired the exclusive licensing of NBE from CSIR-IMTECH for treatment of Ischemic strokes
Morepen Labs begins FY 2018-19 with sound performance in first quarter
Company reports 93 percent rise in its consolidated net profit and 26 percent rise in its consolidated net sales revenue in Q1 of…
Indoco declares Q1FY19 results
Indoco Remedies posted revenues of INR 212.5 crores during the first quarter of FY 2018-19, as against INR 204.2 crores, for the…
Pharma market grows by 12.7 per cent in July 2018
In July, growth due to price was a positive contributor, unlike previous months, when price growth was a negative factor
Benzodiazepines associated with increased risk of Alzheimer’s disease: Study
The medication is commonly used for sleep problems, but its effectiveness for this indication diminishes over weeks or months
Dr R Ananthanarayanan appointed as Cipla’s global COO
He will oversee R&D, manufacturing, supply chain, the API business and the key geographies of North America, Europe and…
Glenmark enters in collaboration with True North
As part of the arrangement, Glenmark’s orthopaedic and pain management business in India and Nepal will be transferred to a new…
Cipla partners with MSN Laboratories for marketing, distribution of generic Xeloda
Capecitabine tablets are indicated as a single agent for adjuvant treatment in patients with Dukes C colon cancer
Multipurpose stalls at railways stations sell generic low-cost medicine
In a written reply in Lok Sabha, Minister of State for Railways, Rajen Gohain said at present, three chemist stalls are…
Hester Biosciences Q1FY19 results: Sales up by 32%, profitability up by 57%
The main drivers for the improvement were reduction in the costs of goods sold and better inventory management
AstraZeneca receives marketing permission for Osimertinib to treat non-small cell lung cancer in…
Osimertinib (TagrissoTM) will be used as 1st line treatment for NSCLC offering potential new standard of care
ACG Inspection partners with Verinetics to further strengthen fight against falsified medicines
With this partnership, ACG Inspections is looking to implement an add-on security layer to provide Multi-Factor authentication to…